Apr. 9—Medical Center Hospital is proud to announce that Dr. Manohar Angirekula, Dr. Adam Farber and Dr. Fernando Boccalandro successfully implanted the first WATCHMAN FLX Pro Device on April 1. MCH ...

Columbus Regional Health Heart & Vascular announced that its cardiovascular services team recently completed its 100th ...

Shaped like a small jellyfish or pumpkin no bigger than the size of a ping pong ball, the WATCHMAN device helps prevent stroke in people with atrial fibrillation (A-fib) by sealing off part of the ...

MedStar Heart & Vascular Institute now offers patients with irregular heart rhythm a minimally invasive option to reduce the risk of stroke, as well as enable stopping long-term use of blood thinning ...

CHICAGO, IL—Reports of device embolization during the limited market rollout of the next-generation Watchman FLX left atrial appendage closure device in Europe have caused manufacturer Boston ...

GAITHERSBURG, MD (updated December 12, 2013) — A second time around the regulatory block appears to be the charm for the Watchman(Boston Scientific), an investigative device that can be used instead ...

Medicare covers Watchman surgery if it is deemed medically necessary to reduce stroke risk in people with nonvalvular atrial fibrillation. Medicare parts A and B and Medicare Advantage may cover ...

In a population largely consisting of patients with nonvalvular A-fib who have contraindications to warfarin therapy, implantation of the Watchman left atrial appendage (LAA) closure device appears ...

Boston Scientific has finally received FDA approval for its Watchman Heart Device after two failed attempts. The device, which has been in markets outside of U.S. since 2005, has struggled to gain ...

Shares of Boston Scientific CorporationBSX rose 1.4% to close at $17.87 on Friday, subsequent to the company's receipt of the CE Mark for its next-generation WATCHMAN FLX Left Atrial Appendage Closure ...

Surgeons at two Southern California hospitals on Monday implanted a controversial heart device that struggled for years to gain the approval of the U.S. Food and Drug Administration. The Watchman ...